Electronic cigarettes for smoking cessation

Cochrane Database of Systematic Reviews

Volumn 2021, Issue 4, 2021, Pages

  Hartmann Boyce, Jamie ^a   McRobbie, Hayden ^b   Lindson, Nicola ^a   Bullen, Chris ^c   Begh, Rachna ^a   Theodoulou, Annika ^a   Notley, Caitlin ^d   Rigotti, Nancy A ^e   Turner, Tari ^f   Butler, Ailsa R ^a   Fanshawe, Thomas R ^a   Hajek, Peter ^g  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f MONASH UNIVERSITY   (Australia)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINE; NICOTINIC AGENT;

BEHAVIOURAL SUPPORT; BLOOD OXYGEN TENSION; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; COUGHING; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FRACTIONAL EXHALED NITRIC OXIDE; HEADACHE; HEART RATE; HUMAN; INTERMETHOD COMPARISON; LUNG FUNCTION; META ANALYSIS; MOUTH DISEASE; MOUTH IRRITATION; NAUSEA; NICOTINE REPLACEMENT THERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; SMOKING CESSATION; SOCIAL SUPPORT; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; THROAT IRRITATION; COHORT ANALYSIS; ELECTRONIC CIGARETTE; EPIDEMIOLOGY; MIDDLE AGED; PROCEDURES; PUBLISHING; SMOKING; SMOKING PREVENTION; STATISTICAL BIAS; VAPING;

BIAS; CARBON MONOXIDE; COHORT STUDIES; ELECTRONIC NICOTINE DELIVERY SYSTEMS; HUMANS; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; OUTCOME ASSESSMENT, HEALTH CARE; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING; SMOKING CESSATION; SMOKING PREVENTION; TOBACCO USE CESSATION DEVICES; VAPING;

EID: 85104956727     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010216.pub5     Document Type: Review

References (342)

1. Adriaens K, Van Gucht D, Declerck P, Baeyens F. Effectiveness of the electronic cigarette: an eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. International Journal of Environmental Research and Public Health 2014;11(11):11220-48. x-wiley/crsRef/4359023
2. Baldassarri SR, Bernstein SL, Chupp GL, Slade MD, Fucito LM, Toll BA. Electronic cigarettes for adults with tobacco dependence enrolled in a tobacco treatment program: a pilot study. Addictive Behaviors May 2018;80:1-5. x-wiley/crsRef/14702526
3. NCT02498145. Short term effects of electronic cigarettes in tobacco dependent adults. clinicaltrials.gov/show/NCT02498145 (accessed 17 February 2016). x-wiley/crsRef/14702527
4. ACTRN12616001641482. Tobacco harm reduction with vaporised nicotine (THRiVe): feasibility study. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12616001641482 (first received 28 November 2016). x-wiley/crsRef/14702529
5. Bell S, Dean J, Gilks C, Boyd MA, Fitzgerald L, Mutch A, et al. Tobacco harm reduction with vaporised nicotine (THRiVe): the study protocol of an uncontrolled feasibility study of novel nicotine replacement products among people living with HIV who smoke. International Journal of Environmental Research and Public Health 2017;14(7):799. x-wiley/crsRef/14702530
6. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes and smoking cessation: a quandary? - Authors' reply. Lancet 2014;383(9915):408-9. x-wiley/crsRef/2995701
7. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013;382(9905):1629-37. x-wiley/crsRef/2995702
8. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J. Do electronic cigarettes help smokers quit? Results from a randomised controlled trial [Abstract]. In: European Respiratory Society Annual Congress, 2013 September 7 - 11, Barcelona, Spain. Vol. 42. 2013:215s-[P1047]. x-wiley/crsRef/2995703
9. Bullen C, Williman J, Howe C, Laugesen M, McRobbie H, Parag V, et al. Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation. BMC Public Health 2013;13:210. x-wiley/crsRef/2995704
10. O'Brien B, Knight-West O, Walker N, Parag V, Bullen C. E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial. Tobacco Induced Diseases 2015;13(1):5. x-wiley/crsRef/4359035
11. Campagna D, Cibella F, Caponnetto P, Amaradio MD, Caruso M, Morjaria JB, et al. Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes. European Journal of Clinical Investigation 2016;46(8):698-706. x-wiley/crsRef/14702531
12. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PlOS One 2013;8(6):e66317. x-wiley/crsRef/14702532
13. Cibella F, Campagna D, Caponnetto P, Amaradio MD, Caruso M, Russo C, et al. Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes. Clinical Science 2016;130(21):1929–37. x-wiley/crsRef/14702533
14. Farsalinos K, Cibella F, Caponnetto P, Campagna D, Morjaria JB, Battaglia E, et al. Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes. Internal and Emergency Medicine 2016;11(1):85-94. x-wiley/crsRef/14702534
15. NCT01164072. Efficacy and safety of an electronic nicotine delivery device (e-cigarette). clinicaltrials.gov/ct2/show/NCT01164072 (first received 16 July 2010). x-wiley/crsRef/14702535
16. NCT01194583. Efficacy and safety of an electronic nicotine delivery device (e-cigarette) without nicotine cartridges. clinicaltrials.gov/ct2/show/NCT01194583 (first received 3 September 2010). x-wiley/crsRef/14702536
17. Russo C, Cibella F, Caponnetto P, Campagna D, Maglia M, Frazzetto E, et al. Evaluation of post cessation weight gain in a 1-year randomized smoking cessation trial of electronic cigarettes. Scientific Reports 2016;6:18763. x-wiley/crsRef/4359036
18. Caponnetto P, Auditore R, Russo C, Cappello GC, Polosa R. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. International Journal of Environmental Research and Public Health 2013;10(2):446-61. x-wiley/crsRef/2995708
19. Minutolo G, Caponnetto P, Auditore R, Russo C, Polosa R. Management of smoking reduction and cessation in inpatients with schizophrenia: Impact of electronic cigarettes. European Neuropsychopharmacology 2013;23:S581-2. x-wiley/crsRef/2995709
20. Carpenter MJ, Heckman BW, Wahlquist AE, Wagener TL, Goniewicz ML, Gray KM, et al. A naturalistic, randomized pilot trial of e-cigarettes: uptake, exposure, and behavioral effects. Cancer Epidemiology, Biomarkers & Prevention 2017;26(12):1795-803. x-wiley/crsRef/14702538
21. NCT02357173. A trial of e-cigarettes: natural uptake, patterns and impact of use. clinicaltrials.gov/show/NCT02357173 (accessed 17 February 2016). x-wiley/crsRef/14702539
22. Smith TT, Wahlquist AE, Heckman BW, Cummings KM, Carpenter MJ. Impact of e-cigarette sampling on cigarette dependence and reinforcement value. Nicotine & Tobacco Research 2020;22(2):297-301. x-wiley/crsRef/14702540
23. Czoli CD, Fong GT, Goniewicz ML, Hammond D. Biomarkers of exposure among "dual users" of tobacco cigarettes and electronic cigarettes in Canada. Nicotine and Tobacco Research 2019;21(9):1259-66. x-wiley/crsRef/17071976
24. Dawkins L, Bauld L, Ford A, Robson D, Hajek P, Parrott S, et al. A cluster feasibility trial to explore the uptake and use of e-cigarettes versus usual care offered to smokers attending homeless centres in Great Britain. PLOS One 2020;15(10). x-wiley/crsRef/17071978 [ISRCTN14140672]
25. ISRCTN14140672. Exploring the use and uptake of e-cigarettes for homeless smokers. www.isrctn.com/ISRCTN14140672 (first received 7 November 2018). x-wiley/crsRef/17071979
26. Eisenberg MJ, Hébert-Losier M, Windle SB, Greenspoon T, Brandys T, Fülöp T. Effect of e-cigarettes plus counseling vs counseling alone on smoking cessation: a randomized clinical trial. JAMA 2020;324(18):1844-54. x-wiley/crsRef/17071981
27. Hebert-Losier A, Filion KB, Windle SB, Eisenberg MJ. A randomized controlled trial evaluating the efficacy of e-cigarette use for smoking cessation in the general population: E3 trial design. Canadian Journal of Cardiology Open 2020;2(3):168-75. x-wiley/crsRef/17071982 [NCT02417467]
28. NCT02417467. Evaluating the efficacy of e-cigarette use for smoking cessation (E3) trial. clinicaltrials.gov/show/NCT02417467 (accessed 17 February 2016). x-wiley/crsRef/17071983
29. Ely J. Evaluation of the use of electric cigarettes in a rural smoking cessation program. Available online at: digitalunc.coalliance.org/fedora/repository/cogru:4161 [no longer available] 2013 (accessed 1st November 2014). x-wiley/crsRef/2995714
30. Felicione NJ, Enlow P, Elswick D, Long D, Sullivan CR, Blank MD. A pilot investigation of the effect of electronic cigarettes on smoking behavior among opioid-dependent smokers. Addictive Behaviors 2019;91:45-50. x-wiley/crsRef/14702542
31. George J, Hussain M, Vadiveloo T, Ireland S, Hopkinson P, Struthers AD, et al. Cardiovascular effects of switching from tobacco cigarettes to electronic cigarettes. Journal of the American College of Cardiology 2019;74(25):3112-20. x-wiley/crsRef/14702544
32. NCT02878421. Vascular EffectS of regUlar cigarettes Versus electronIc cigarette USe (VESUVIUS). clinicaltrials.gov/ct2/show/NCT02878421 (first received 25 August 2016). x-wiley/crsRef/14702545
33. Goniewicz ML, Gawron M, Smith DM, Peng M, Jacob P 3rd, Benowitz NL. Exposure to nicotine and selected toxicants in cigarette smokers who switched to electronic cigarettes: a longitudinal within-subjects observational study. Nicotine & Tobacco Research 2017;19(2):160-7. x-wiley/crsRef/14702548
34. ACTRN12617000849392. The QuitNic Study: a pilot study of electronic nicotine devices for smoking cessation with drug and alcohol clients. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372198 (first received 8 June 2017). x-wiley/crsRef/17271873
35. Bonevski B, Manning V, Wynne O, Gartner C, Borland R, Baker A, et al. QuitNic: A pilot randomised controlled trial comparing nicotine vaping products with nicotine replacement therapy for smoking cessation following residential detoxification. Nicotine and Tobacco Research 2021;23(3):462-70. x-wiley/crsRef/17071984
36. Guillaumier A, Manning V, Wynne O, Gartner C, Borland R, Baker AL, et al. Electronic nicotine devices to aid smoking cessation by alcohol- and drug-dependent clients: protocol for a pilot randomised controlled trial. Trials 2018;19:415. x-wiley/crsRef/14702550
37. Hajek P, Corbin L, Ladmore D, Spearing E. Adding e-cigarettes to specialist stop-smoking treatment: City of London pilot project. Journal of Addiction Research & Therapy 2015;6(244):(online ahead of print). x-wiley/crsRef/4359038 [DOI: 10.4172/2155-6105.1000244]
38. Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. New England Journal of Medicine 2019;380(7):629-37. x-wiley/crsRef/14702552
39. Hajek P, Phillips-Waller A, Przulj D, Pesola F, Smith KM, Bisal N, et al. E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT. Health Technology Assessment 2019;23(43):1-82. x-wiley/crsRef/17071985 [ISRCTN60477608]
40. ISRCTN60477608. The efficacy of e-cigarettes compared with nicotine replacement therapy, when used within the UK stop smoking service. www.isrctn.com/ISRCTN60477608 2014 (first received 2 April 2015). x-wiley/crsRef/14702553
41. Li J, Hajek P, Pesola F, Wu Q, Phillips-Waller A, Przulj D, et al. Cost-effectiveness of e-cigarettes compared with nicotine replacement therapy in stop smoking services in England (TEC study): a randomized controlled trial. Addiction 2020;115(3):507-17. x-wiley/crsRef/14702554
42. Halpern SD, Harhay MO, Saulsgiver K, Brophy C, Troxel AB, Volpp KG. A pragmatic trial of e-cigarettes, incentives, and drugs for smoking cessation. New England Journal of Medicine 2018;378(24):2302-10. x-wiley/crsRef/14702556
43. NCT02328794. Randomized clinical trial to reduce harm from tobacco. clinicaltrials.gov/show/NCT02357173 (accessed 17 February 2016). x-wiley/crsRef/14702557
44. Hatsukami D, Meier E, Lindgren BR, Anderson A, Reisinger S, Norton K, et al. A randomized clinical trial examining the effects of instructions for electronic cigarette use on smoking-related behaviors, and biomarkers of exposure. Nicotine & Tobacco Research 2020;22(9):1524-32. x-wiley/crsRef/14702559 [DOI: 10.1093/ntr/ntz233]
45. Hickling LM, Perez-Iglesias R, McNeill A, Dawkins L, Moxham J, Ruffell T, et al. A pre-post pilot study of electronic cigarettes to reduce smoking in people with severe mental illness. Psychological Medicine 2019;49(6):1033-40. x-wiley/crsRef/14702561
46. NCT02212041. Acceptability, patterns of use and safety of electronic cigarette in people with mental illness: a pilot study. clinicaltrials.gov/show/NCT02212041 (accessed 17 February 2016). x-wiley/crsRef/14702562
47. Holliday R, Preshaw PM, Ryan V, Sniehotta FF, McDonald S, Bauld L, et al. A feasibility study with embedded pilot randomised controlled trial and process evaluation of electronic cigarettes for smoking cessation in patients with periodontitis. Pilot and Feasibility Studies 2019;5:74. x-wiley/crsRef/14702564
48. ISRCTN17731903. Feasibility study of e-cigarettes in periodontitis. www.isrctn.com/ISRCTN17731903 (first received 27 September 2016). x-wiley/crsRef/14702565
49. Humair J-P, Tango R. Can e-cigarette help patients to reduce or stop smoking in primary care practice? Journal of General Internal Medicine 2014;29:S480. x-wiley/crsRef/2995720
50. Ikonomidis I, Vlastos D, Kourea K, Kostelli G, Varoudi M, Pavlidis G, et al. Electronic cigarette smoking increases arterial stiffness and oxidative stress to a lesser extent than a single conventional cigarette: an acute and chronic study. Circulation 2018;137(3):303-6. x-wiley/crsRef/14702567
51. NCT03039920. The effects of electronic cigarette smoking on the arterial wall and endothelial glycocalyx properties of smokers. clinicaltrials.gov/ct2/show/NCT03039920 (first received 1 February 2017). x-wiley/crsRef/14702568
52. Ikonomidis I, Katogiannis K, Kostelli G, Kourea K, Kyriakou E, Kypraiou A, et al. Effects of electronic cigarette on platelet and vascular function after four months of use. Food and Chemical Toxicology 2020;141:111389. x-wiley/crsRef/17071987
53. Ioakeimidis N, Vlachopoulos C, Georgakopoulos C, Abdelrasoul M, Skliros N, Katsi V, et al. Smoking cessation rates with varenicline and electronic cigarettes in relapsed smokers with a history of acute coronary syndrome. European Heart Journal 2018;39(Suppl_1):242. x-wiley/crsRef/14702570
54. Kumral TL, Saltürk Z, Yildirim G, Uyar Y, Berkiten G, Atar Y, et al. How does electronic cigarette smoking affect sinonasal symptoms and nasal mucociliary clearance? B-ENT 2016;12(1):17-21. x-wiley/crsRef/14702574
55. Lee SM, Tenney R, Wallace A, Arjojmandi M. The end perioperative smoking pilot study: a randomized trial comparing e-cigarettes versus nicotine patch. Canadian Journal of Anesthesia 2017;64(1 Supplement 1):S48-S49. x-wiley/crsRef/14702576
56. Lee SM, Tenney R, Wallace AW, Arjomandi M. E-cigarettes versus nicotine patches for perioperative smoking cessation: a pilot randomized trial. PeerJ 2018;6(9):e5609. x-wiley/crsRef/14702577
57. NCT02482233. A pilot randomized controlled clinical trial - "Electronic nicotine delivery device (e-cigarette) for perioperative smoking cessation in veterans". clinicaltrials.gov/show/NCT02482233 (accessed 17 February 2016). x-wiley/crsRef/14702578
58. KCT0001277. Effect of an electronic cigarette for smoking reduction and cessation in Korean male smokers: a randomized, controlled study. KCT0001277 2014 (accessed 15 August 2016). x-wiley/crsRef/14702580
59. Lee SH, Ahn SH, Cheong YS. Effect of electronic cigarettes on smoking reduction and cessation in Korean male smokers: a randomized controlled study. Journal of the American Board of Family Medicine 2019;32(4):567-74. x-wiley/crsRef/14702581
60. Lucchiari C, Masiero M, Mazzocco K, Veronesi G, Maisonneauve P, Jemos C, et al. Benefits of e-cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months. Addictive Behaviours 2020;103:106222. x-wiley/crsRef/17071988
61. Lucchiari C, Masiero M, Veronesi G, Maisonneuve P, Spina S, Jemos C, et al. Benefits of e-cigarettes among heavy smokers undergoing a lung cancer screening program: randomized controlled trial protocol. JMIR Research Protocols 2016;5(1):e21. x-wiley/crsRef/14702583 [PMID: 26842790]
62. Masiero M, Lucchiari C, Mazzocco K, Veronesi G, Maisonneuve P, Jemos C, et al. E-cigarettes may support smokers with high smoking-related risk awareness to stop smoking in the short run: preliminary results by randomized controlled trial. Nicotine and Tobacco Research 2019;21(1):119-126. x-wiley/crsRef/17071989 [NCT02422914]
63. Masiero M, Lucchiari C, Mazzocco K, Veronesi G, Maisonneuve P Jemos C, et al. Corrigendum: E-cigarettes may support smokers with high smoking-related risk awareness to stop smoking in the short run: preliminary results by randomized controlled trial. Nicotine and Tobacco Research 2020;22(4):594-5. x-wiley/crsRef/17071990 [NCT02422914]
64. NCT02422914. Benefits of tobacco free cigarette among heavy smokers undergoing a lung cancer screening program: a randomized controlled study. clinicaltrials.gov/show/NCT02422914 (accessed 17 February 2016). x-wiley/crsRef/14702584
65. Martner SG, Dallery J. Technology-based contingency management and e-cigarettes during the initial weeks of a smoking quit attempt. Journal of Applied Behavior Analysis 2019;52(4):928-43. x-wiley/crsRef/14702586
66. McRobbie H, Goniewicz M, Phillips A, Myers-Smith K, West O, Hajek P. Effects of the use of electronic cigarettes with and without concurrent smoking on acrolein delivery POS4-33. In: Society for Research on Nicotine and Tobacco, 20th Annual Meeting, Seattle, Washington. 2014:13. x-wiley/crsRef/2995722 [www.srnt.org/conferences/2014/pdf/SRNT_2014_Rapids_C.pdf]
67. McRobbie H, Phillips A, Goniewicz ML, Smith KM, Knight-West O, Przulj D, et al. Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Cancer Prevention Research (Philadelphia, Pa.) 2015;8(9):873-8. x-wiley/crsRef/14702587
68. NCT01714778. Toxins and Delivery in E-cigarette USers (TADEUS). clinicaltrials.gov/ct2/show/NCT01714778 (first received 26 October 2012). x-wiley/crsRef/14702588
69. Meier E, Wahlquist AE, Heckman BW, Cummings KM, Froeliger B, Carpenter MJ. A pilot randomized crossover trial of electronic cigarette sampling among smokers. Nicotine & Tobacco Research 2017;19(2):176-82. x-wiley/crsRef/14702590
70. NCT02648178. Evaluation of appeal and impact of e-cigarettes among chronic smokers with smoking-related cancers. clinicaltrials.gov/show/NCT02648178 (accessed 17 February 2016). x-wiley/crsRef/4359108
71. NCT02918630. E-cigarettes to promote smoking reduction among individuals with schizophrenia. clinicaltrials.gov/ct2/show/NCT02918630 (first received 5 July 2018). x-wiley/crsRef/14702592
72. NCT01898169. Evaluation of short-term safety and use patterns of an electronic nicotine delivery system. clinicaltrials.gov/ct2/show/NCT01898169 (first received 12 July 2013). x-wiley/crsRef/14702593
73. Nides MA, Leischow SJ, Bhatter M, Simmons M. Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system. American Journal of Health Behavior 2014;38(2):265-74. x-wiley/crsRef/2995724
74. NCT01775787. Effects of Electronic Cigarettes on Nicotine Concentrations (ECIG). clinicaltrials.gov/ct2/show/NCT01775787 (first received 25 January 2013). x-wiley/crsRef/14702594
75. Oncken CA, Litt MD, McLaughlin LD, Burki NA. Nicotine concentrations with electronic cigarette use: effects of sex and flavor. Nicotine & Tobacco Research 2015;17(4):473-8. x-wiley/crsRef/4359044
76. Swedeh MA, Oncken C, Burki NK. Acute effects of electronic cigarettes on airway function in human subjects. In: American Thoracic Society International Conference Abstracts. Vol. 189. 2014:A4089. x-wiley/crsRef/4359045
77. Ozga-Hess JE, Felicione NJ, Ferguson SG, Dino G, Elswick D, Whitworth C, et al. Piloting a clinical laboratory method to evaluate the influence of potential modified risk tobacco products on smokers' quit-related motivation, choice, and behaviour. Addictive Behaviors 2019;99:106105. x-wiley/crsRef/17071992
78. Pacifici R, Pichini S, Graziano S, Pellegrini M, Massaro G, Beatrice F. Successful nicotine intake in medical assisted use of e-cigarettes: a pilot study. International Journal of Environmental Research and Public Health 2015;12(7):7638-46. x-wiley/crsRef/4359047
79. NCT01195597. Smoking cessation and reduction with an electronic nicotine delivery device (ENDD). clinicaltrials.gov/ct2/show/NCT01195597 (first received 6 September 2010). x-wiley/crsRef/14702595
80. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 2011;11:786. x-wiley/crsRef/2995726
81. Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Internal and Emergency Medicine 2014;9(5):537-46. x-wiley/crsRef/2995727
82. NCT02124200. High Cessation Rates in Smokers Using Personal Vaporizers (VAPECIG). clinicaltrials.gov/ct2/show/NCT02124200 (first received 28 April 2014). x-wiley/crsRef/14702596
83. Polosa R, Caponnetto P, Maglia M, Morjaria JB, Russo C. Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit. BMC Public Health 2014;14:1159. x-wiley/crsRef/4359049
84. Polosa R, Caponnetto P, Cibella F, Le-Houezec J. Quit and smoking reduction rates in vape shop consumers: a prospective 12-month survey. International Journal of Environmental Research and Public Health 2015;12(4):3428-38. x-wiley/crsRef/4359051
85. Pratt SI, Sargent J, Daniels L, Santos MM, Brunette M. Appeal of electronic cigarettes in smokers with serious mental illness. Addictive Behaviors 2016;59:30-4. x-wiley/crsRef/14702598
86. Pulvers K, Emami AS, Nollen NL, Romero DR, Strong DR, Benowitz NL, et al. Tobacco consumption and toxicant exposure of cigarette smokers using electronic cigarettes. Nicotine & Tobacco Research 2018;20(2):206-14. x-wiley/crsRef/14702600
87. Pulvers K, Nollen NL, Rice M, Schmid CH, Qu K, Benowitz NL, et al. Effect of pod e-cigarettes vs cigarettes on carcinogen exposure among African American and Latinx smokers: a randomized clinical trial. JAMA Netw0rk Open 2020;3(11):e2026324. x-wiley/crsRef/17071994
88. Scheibein F, McGirr K, Morrison A, Roche, Wells JS. An exploratory non-randomized study of a 3-month electronic nicotine delivery system (ENDS) intervention with people accessing a homeless supported temporary accommodation service (STA) in Ireland. Harm Reduction Journal 2020;17(1):73. x-wiley/crsRef/17071996
89. Smith TT, Heckman BW, Wahlquist AE, Cummings KM, Carpenter MJ. The impact of e-liquid propylene glycol and vegetable glycerin ratio on ratings of subjective effects, reinforcement value, and use in current smokers. Nicotine & Tobacco Research 2020;22(5):791-7. x-wiley/crsRef/14702602
90. Stein MD, Caviness C, Grimone K, Audet D, Anderson BJ, Bailey GL. An open trial of electronic cigarettes for smoking cessation among methadone-maintained smokers. Nicotine & Tobacco Research 2016;18(5):1157-62. x-wiley/crsRef/14702604
91. Strasser AA, Souprountchouk V, Kaufmann A, Blazekovic S, Leone F, Benowitz NL, et al. Nicotine replacement, topography, and smoking phenotypes of e-cigarettes. Tobacco Regulatory Science 2016;2(4):352-62. x-wiley/crsRef/14702606
92. NCT02628964. Assessing the use of electronic cigarettes (e-cigarettes) as a harm reduction strategy. clinicaltrials.gov/show/NCT02628964 (accessed 17 February 2016). x-wiley/crsRef/14702608
93. Tseng TY, Ostroff JS, Campo A, Gerard M, Kirchner T, Rotrosen J, et al. A randomized trial comparing the effect of nicotine versus placebo electronic cigarettes on smoking reduction among young adult smokers. Nicotine & Tobacco Research 2016;18(10):1937-43. x-wiley/crsRef/14702609
94. Valentine GW, Hefner K, Jatlow PI, Rosenheck RA, Gueorguieva R, Sofuoglu M. Impact of e-cigarettes on smoking and related outcomes in veteran smokers with psychiatric comorbidity. Journal of Dual Diagnosis 2018;14(1):2-13. x-wiley/crsRef/14702611
95. Van Staden SR, Groenewald M, Engelbrecht R, Becker PJ, Hazelhurst LT. Carboxyhaemoglobin levels, health and lifestyle perceptions in smokers converting from tobacco cigarettes to electronic cigarettes. South African Medical Journal 2013;103(11):865-8. x-wiley/crsRef/2995731
96. Lopez AA, Cobb CO, Yingst JM, Veldheer S, Hrabovsky S, Yen MS, et al. A transdisciplinary model to inform randomized clinical trial methods for electronic cigarette evaluation. BMC Public Health 2016;16(1):217. x-wiley/crsRef/14702613 [PMCID:: PMC4778292] [PMID: 26941050]
97. NCT02342795. Randomized controlled trial methods for novel tobacco products evaluation. clinicaltrials.gov/show/NCT02342795 (accessed 17 February 2016). x-wiley/crsRef/14702614
98. Veldheer S, Yingst J, Midya V, Hummer B, Lester C, Krebs N,. Pulmonary and other health effects of electronic cigarette use among adult smokers participating in a randomized controlled smoking reduction trial. Addictive Behaviors 2019;91:95-101. x-wiley/crsRef/14702615
99. Yingst J, Foulds J, Veldheer S, Cobb CO, Yen M, Hrabovsky S, et al. Measurement of electronic cigarette frequency of use among smokers participating in a randomized controlled trial. Nicotine & Tobacco Research 2020;22(5):699-704. x-wiley/crsRef/17071997 [NCT02342795]
100. Wadia R, Booth V, Yap HF, Moyes DL. A pilot study of the gingival response when smokers switch from smoking to vaping. British Dental Journal 2016;221(11):722-6. x-wiley/crsRef/14702617
101. Cravo AS, Bush J, Sharma G, Savioz R, Martin C, Craige S, et al. A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks. Regulatory Toxicology and Pharmacology 2016;81:S1-S14. x-wiley/crsRef/14702619
102. NCT02029196. A randomised, parallel group, multi-centre study to evaluate the safety profile of the ITG EVP G1 product. clinicaltrials.gov/show/NCT02029196 (accessed 16 July 2014). x-wiley/crsRef/14702620
103. NCT02143310. A multi-centre study to evaluate the safety of use of electronic vapour products for two years. clinicaltrials.gov/show/NCT02143310 (accessed 16 July 2014). x-wiley/crsRef/14702621
104. Walele T, Bush J, Koch A, Savioz R, Martin C, O'Connell G. Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting. Regulatory Toxicology and Pharmacology 2018;92:226-38. x-wiley/crsRef/14702622
105. NCT02521662. A randomised-controlled clinical trial to evaluate the effectiveness and safety of combining nicotine patches with e-cigarettes (with and without nicotine) plus behavioural support, on smoking abstinence. clinicaltrials.gov/show/NCT02521662 (accessed 17 February 2016). x-wiley/crsRef/14702624
106. Walker N, Parag V, Verbiest M, Laking G, Laugesen M, Bullen C. Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial. Lancet. Respiratory Medicine 2020;8(1):54-64. x-wiley/crsRef/14702625
107. Walker N, Verbiest M, Kurdziel T, Laking G, Laugesen M, Parag V, et al. Effectiveness and safety of nicotine patches combined with e-cigarettes (with and without nicotine) for smoking cessation: study protocol for a randomised controlled trial. BMJ Open 2019;9(2):e023659. x-wiley/crsRef/14702626
108. Yingst J, Foulds J, Zurlo J, Steinberg MB, Eissenberg T, Du P. Acceptability of electronic nicotine delivery systems (ENDS) among HIV positive smokers. AIDS Care 2020;32(10):1224-8. x-wiley/crsRef/17071999
109. Adkison SE, O'Connor RJ, Bansal-Travers M, Hyland A, Borland R, Yong HH, et al. Electronic nicotine delivery systems: international tobacco control four-country survey. American Journal of Preventive Medicine 2013;44(3):207-15. x-wiley/crsRef/2995733
110. Al-Delaimy WK, Myers MG, Leas EC, Strong DR, Hofstetter CR. E-cigarette use in the past and quitting behavior in the future: a population-based study. American Journal of Public Health 2015;105(6):1213-9. x-wiley/crsRef/4359025
111. Donzelli A. E-cigarettes may impair ability to quit, but other explanations are possible. American Journal of Public Health 2015;105(11):e1. x-wiley/crsRef/4359026
112. Anonymous. E-cigarettes best other cessation tools. Cancer Discovery 2019;9(4):OF3. x-wiley/crsRef/14702628
113. Battista L, Di Iorio M, Tancredi M, Acconcia MC, Torromeo C, Barilla F, et al. Cardiovascular effects of electronic cigarettes. Circulation 2013;128:A16755. x-wiley/crsRef/2995735
114. Bianco CL, Pratt SI, Ferron JC, Brunette MF. Electronic cigarette use during a randomized trial of interventions for smoking cessation among Medicaid beneficiaries with mental illness. Journal of Dual Diagnosis 2019;15(3):184-91. x-wiley/crsRef/14702630
115. Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine & Tobacco Research 2015;17(2):127-33. x-wiley/crsRef/4359055
116. Biondi-Zoccai G, Sciarretta S, Bullen C, Nocella C, Violi F, Loffredo L, et al. Acute effects of heat-not-burn, electronic vaping, and traditional tobacco combustion cigarettes: the Sapienza University of Rome-Vascular Assessment of Proatherosclerotic Effects of Smoking (SUR - VAPES) 2 randomized trial. Journal of the American Heart Association 2019;8(6):e010455. x-wiley/crsRef/14702632
117. Biondi-Zoccai G, Carnevale R, Vitali M, Tritapepe L, Martinelli O, Macrina F, et al. A randomized trial comparing the acute coronary, systemic, and environmental effects of electronic vaping cigarettes versus heat-not-burn cigarettes in smokers of combustible cigarettes undergoing invasive coronary assessment: rationale and design of the SUR-VAPES 3 trial. Minerva Cardioangiologica 2020;68(6):548-55. x-wiley/crsRef/17072001
118. Barton MK. Electronic cigarettes did not help patients with cancer stop smoking. CA: a cancer journal for clinicians 2015;65(2):85-6. x-wiley/crsRef/4359028
119. Borderud SP, Li Y, Burkhalter JE, Sheffer CE, Ostroff JS. Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer 2014;120(22):3527-35. x-wiley/crsRef/4359029
120. Fillon M. Electronic cigarettes might not help cancer patients quit smoking. Journal of the National Cancer Institute 2015;107(1):496. x-wiley/crsRef/4359030
121. Brose LS, Hitchman SC, Brown J, West R, McNeill A. Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1-year follow-up. Addiction 2015;110(7):1160-8. x-wiley/crsRef/4359032
122. Brown J, West R, Beard E, Michie S, Shahab L, McNeill A. Prevalence and characteristics of e-cigarette users in Great Britain: Findings from a general population survey of smokers. Addictive Behaviors 2014;39(6):1120-5. x-wiley/crsRef/4359033
123. Hitchman SC, Brose LS, Brown J, Robson D, McNeill A. Associations between e-cigarette type, frequency of use, and quitting smoking: findings from a longitudinal online panel survey in Great Britain. Nicotine & Tobacco Research 2015;17(10):1187-94. x-wiley/crsRef/4359034
124. Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014;109(9):1531-40. x-wiley/crsRef/2995737
125. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tobacco Control 2010;19(2):98-103. x-wiley/crsRef/2995739
126. Bullen C, Verbiest M, Galea-Singer S, Kurdziel T, Laking G, Newcombe D, et al. The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial. BMC Public Health 2018;18(1):596. x-wiley/crsRef/14702634
127. Caponnetto P, Maglia M, Polosa R. Efficacy of smoking cessation with varenicline plus counselling for e-cigarettes users (VAREVAPE): a protocol for a randomized controlled trial. Contemporary Clinical Trials Communications 2019;15:100412. x-wiley/crsRef/14702636
128. Cavarretta E, Sciarretta S, Nocella C, Peruzzi M, Marullo AG, Loffredo L, et al. Subjective smoking satisfaction between heat-not-burn, electronic vaping, and traditional tobacco combustion cigarettes: a sub-analysis of the SUR-VAPES 2 trial. European Journal of Preventive Cardiology 2019;26(Supplement 1):S114. x-wiley/crsRef/17072003
129. Chaumont M, de Becker B, Zaher W, Culie A, Deprez G, Melot C, et al. Differential Effects of E-Cigarette on Microvascular Endothelial Function, Arterial Stiffness and Oxidative Stress: a Randomized Crossover Trial. Scientific reports 2018;8(1):10378. x-wiley/crsRef/14702638
130. Chaumont M, El Channan M, Bernard A, Lesage A, Deprez G, Van Muylem A, et al. Short-term high wattage e-cigarette cessation improves cardiorespiratory outcomes in regular users: a randomized crossover trial. Journal of Hypertension 2019;Conference: 29th European Meeting on Hypertension and Cardiovascular Protection, ESH 2019. Italy. 37(Supplement 1):e8-9. x-wiley/crsRef/14702640
131. Chausse P, Naughton G, Dutheil F. Electronic cigarettes: the resistance value of the heating filament could be the key to lung toxicity. Chest 2015;148(1):e29-30. x-wiley/crsRef/4359057
132. Choi K, Forster JL. Beliefs and experimentation with electronic cigarettes: a prospective analysis among young adults. American Journal of Preventive Medicine 2014;6(2):175-8. x-wiley/crsRef/2995711
133. Choi K Forster JL. Authors' Response to: Context on use is needed before public health recommendations are made about e-cigarettes. Americal Journal of Preventive Medicine 2014;46(6):e58-59. x-wiley/crsRef/2995712
134. Chorti M, Poulianiti K, Jamurtas A, Kostikas K, Tzatzarakis M, Vynias D, et al. Effects of active and passive electronic and tobacco cigarette smoking on lung function (P08-02). Toxicology Letters 2012;211:S64. x-wiley/crsRef/2995741
135. Collins SE, Nelson LA, Stanton J, Mayberry N, Ubay T, Taylor EM, et al. Harm reduction treatment for smoking (HaRT-S): findings from a single-arm pilot study with smokers experiencing chronic homelessness. Substance Abuse 2019;40(2):229-39. x-wiley/crsRef/14702642
136. Cook R, Davidson P, Martin R. E-cigarettes helped more smokers quit than nicotine replacement therapy. BMJ 2019;365:l2036. x-wiley/crsRef/14702644
137. Cox S, Dawkins L, Doshi J, Cameron J. Effects of e-cigarettes versus nicotine replacement therapy on short-term smoking abstinence when delivered at a community pharmacy. Addictive Behaviors Reports 2019;10:100202. x-wiley/crsRef/14702646
138. Czogala J, Cholewinski M, Kutek A, Zielinska-Danch W. Evaluation of changes in hemodynamic parameters after the use of electronic nicotine delivery systems among regular cigarette smokers. Przeglad Lekarski 2012;69(10):841-5. x-wiley/crsRef/2995743
139. D'Ruiz CD, O'Connell G, Graff DW, Yan XS. Measurement of cardiovascular and pulmonary function endpoints and other physiological effects following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers. Regulatory Toxicology and Pharmacology 2017;87:36-53. x-wiley/crsRef/14702648
140. Dawkins L, Turner J, Hasna S, Soar K. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition. Addictive Behaviors 2012;37(8):970-3. x-wiley/crsRef/2995745
141. Dawkins L, Turner J, Crowe E. Nicotine derived from the electronic cigarette improves time-based prospective memory in abstinent smokers. Psychopharmacology 2013;227(3):377-84. x-wiley/crsRef/2995747
142. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology 2014;231(2):401-7. x-wiley/crsRef/2995749
143. Douptcheva N, Gmel G, Studer J, Deline S, Etter JF. Use of electronic cigarettes among young Swiss men. Journal of Epidemiology & Community Health 2013;67(12):1075-6. x-wiley/crsRef/2995751
144. Dutra LM, Glantz SA. Electronic cigarettes and conventional cigarette use among U.S. adolescents: a cross-sectional study. JAMA Pediatrics 2014;168(7):610-7. x-wiley/crsRef/2995753
145. Eissenberg T. Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration. Tobacco Control 2010;19(1):87-8. x-wiley/crsRef/2995755
146. Etter JF, Bullen C. A longitudinal study of electronic cigarette users. Addictive Behaviors 2014;39(2):491-4. x-wiley/crsRef/2995716
147. Farsalinos K, Tsiapras D, Kyrzopoulos S, Savvopoulou M, Avramidou E, Vasilopoulou D, et al. Acute effects of using an electronic nicotine-delivery device (e-cigarette) on myocardial function: comparison with the effects of regular cigarettes. European Heart Journal 2012;33:203. x-wiley/crsRef/2995757
148. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovascular Disorders 2014;14:78. x-wiley/crsRef/2995758
149. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of "vapers" who had achieved complete substitution of smoking. Substance Abuse: Research and Treatment 2013;7:139-46. x-wiley/crsRef/2995760
150. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Spyrou A, Voudris V. Impact of flavour variability on electronic cigarette use experience: an internet survey. International Journal of Environmental Research & Public Health 2013;10(12):7272-82. x-wiley/crsRef/2995762
151. Farsalinos K, Tsiapras D, Kyrzopoulos S, Stefopoulos C, Spyrou A, Tsakalou M, et al. Immediate effects of electronic cigarette use on coronary circulation and blood carboxyhemoglobin levels: comparison with cigarette smoking. European Heart Journal 2013;34(Suppl 1):13. x-wiley/crsRef/2995764
152. Farsalinos K, Tsiapras D, Kyrzopoulos S, Spyrou A, Stefopoulos C, Romagna G, et al. Effects of electronic cigarette use on the elastic properties of the ascending aorta in healthy subjects: comparison with the effects of tobacco cigarettes. European Heart Journal Cardiovascular Imaging 2013;14(Suppl 2):ii203. x-wiley/crsRef/2995766
153. Flouris AD, Poulianiti KP, Chorti MS, Jamurtas AZ, Kouretas D, Owolabi EO, et al. Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food and Chemical Toxicology 2012;50(10):3600-3. x-wiley/crsRef/2995768
154. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhalation Toxicology 2013;25(2):91-101. x-wiley/crsRef/2995770
155. Gmel G, Baggio S, Mohler-Kuo M, Daeppen JB, Studer J. E-cigarette use in young Swiss men: is vaping an effective way of reducing or quitting smoking? Swiss Medical Weekly 2016;146:w14271. x-wiley/crsRef/4359059
156. Gottlieb MA. E-cigarettes versus nicotine-replacement therapy for smoking cessation. New England Journal of Medicine 2019;380(20):1974. x-wiley/crsRef/14702652
157. Grana RA, Popova L, Ling PM. A longitudinal analysis of electronic cigarette use and smoking cessation. JAMA Internal Medicine 2014;174(5):812-3. x-wiley/crsRef/2995718
158. James SA, Meier EM, Wagener TL, Smith KM, Neas BR, Beebe LA. E-Cigarettes for immediate smoking substitution in women diagnosed with cervical dysplasia and associated disorders. International Journal of Environmental Health Research 2016;13(3):E288. x-wiley/crsRef/4359061 [DOI: 10.3390/ijerph13030288]
159. NCT01842828. E-Cigarettes as an addition to multi-component treatment for tobacco dependence: a pilot study. clinicaltrials.gov/show/NCT01842828 (accessed 16 July 2014). x-wiley/crsRef/4359062
160. Kasza KA, Bansal-Travers M, O'Connor RJ, Compton WM, Kettermann A, Borek N, et al. Cigarette smokers' use of unconventional tobacco products and associations with quitting activity: findings from the ITC-4 U.S. cohort. Nicotine & Tobacco Research 2013;16(6):672-81. x-wiley/crsRef/2995772
161. Kouretas D, Poulianiti K, Chorti M, Jamurtas A, Kostikas K, Tzatzarakis M, et al. Effects of electronic cigarette and tobacco cigarette smoking on complete blood count (P08-03). Toxicology Letters 2012;211:S64. x-wiley/crsRef/2995774
162. Kousta S. E-cigarettes for smoking cessation. Nature Human Behaviour 2019;3:322. x-wiley/crsRef/14702654
163. Lechner WV, Meier E, Wiener JL, Grant DM, Gilmore J, Judah MR, et al. The comparative efficacy of first- versus second-generation electronic cigarettes in reducing symptoms of nicotine withdrawal. Addiction 2015;110(5):862-7. x-wiley/crsRef/14702656
164. Lee S, Grana RA, Glantz SA. Electronic cigarette use among Korean adolescents: a cross-sectional study of market penetration, dual use, and relationship to quit attempts and former smoking. Journal of Adolescent Health 2014;54(6):684-90. x-wiley/crsRef/2995776
165. Manzoli L, Flacco ME, Fiore M, La Vecchia C, Marzuillo C, Gualano MR, et al. Electronic cigarettes efficacy and safety at 12 months: cohort study. PLOS One 2015;10(6):e0129443. x-wiley/crsRef/4359040
166. Manzoli L, La Vecchia C, Flacco ME, Capasso L, Simonetti V, Boccia S, et al. Multicentric cohort study on the long-term efficacy and safety of electronic cigarettes: study design and methodology. BMC Public Health 2013;13(1):883. x-wiley/crsRef/14702657
167. NCT01785537. The efficacy and safety of electronic cigarettes: a 5-year follow-up study. clinicaltrials.gov/ct2/show/NCT01785537 (first received 7 February 2013). x-wiley/crsRef/14702658
168. Marini S, Buonanno G, Stabile L, Ficco G. Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide. Toxicology and Applied Pharmacology 2014;278(1):9-15. x-wiley/crsRef/2995778
169. Mayor S. E-cigarettes help twice as many smokers quit as nicotine replacement therapy, trial finds. BMJ 2019;364:l473. x-wiley/crsRef/14702660
170. Meltzer LR, Simmons VN, Sutton SK, Drobes DJ, Quinn GP, Meade CD, et al. A randomized controlled trial of a smoking cessation self-help intervention for dual users of tobacco cigarettes and e-cigarettes: intervention development and research design. Contemporary Clinical Trials 2017;60:56-62. x-wiley/crsRef/14702662
171. Miura N, Yuki D, Minami N, Kakehi A, Futama Y. A study to investigate changes in the levels of biomarkers of exposure to selected cigarette smoke constituents in Japanese adult male smokers who switched to a non-combustion inhaler type of tobacco product. Regulatory Toxicology and Pharmacology 2015;71(3):498-506. x-wiley/crsRef/4359064
172. NCT02487953. Electronic Nicotine Delivery Systems (ENDS) as a smoking cessation treatment. clinicaltrials.gov/ct2/show/NCT02487953 (first received 2 July 2015). x-wiley/crsRef/17072005
173. NCT03036644. Comparison of electronic cigarettes and tobacco cigarettes on cardiovascular function and oxidative stress. clinicaltrials.gov/ct2/show/NCT03036644 (first received 30 January 2017). x-wiley/crsRef/14702668
174. NCT03575468. Enhanced e-cigarette coaching intervention for dual users of cigarettes and e-cigarettes. clinicaltrials.gov/ct2/show/NCT03575468 (first received 2 July 2018). x-wiley/crsRef/14702670
175. NCT04107779. Changes in biomarkers of cigarette smoke exposure after switching either exclusively or partly to JUUL ENDS. clinicaltrials.gov/ct2/show/NCT04107779 (first received 27 September 2019). x-wiley/crsRef/14702672
176. Nolan M, Leischow S, Croghan I, Kadimpati S, Hanson A, Schroeder D, et al. Feasibility of electronic nicotine delivery systems in surgical patients. Nicotine & Tobacco Research 2016;18(8):1757-62. x-wiley/crsRef/14702674
177. NTR6224. Electronic cigarettes: an intervention for dual-users. www.who.int/trialsearch/Trial2.aspx?TrialID=NTR6224 (first received 12 January 2017). x-wiley/crsRef/14702733
178. Palamidas A, Gennimata SA, Kaltsakas G, Tsikrika S, Vakali S, Gratziou C, et al. Acute effect of an e-cigarette with and without nicotine on lung function. Tobacco Induced Diseases 2014;12(Suppl 1):A34. x-wiley/crsRef/2995780
179. Pearson JL, Richardson A, Niaura RS, Vallone DM, Abrams DB. E-cigarette awareness, use, and harm perceptions in US adults. American Journal of Public Health 2012;102(9):1758-66. x-wiley/crsRef/2995782
180. Pokhrel P, Fagan P, Little MA, Kawamoto CT, Herzog TA. Smokers who try e-cigarettes to quit smoking: findings from a multiethnic study in Hawaii. American Journal of Public Health 2013;103(9):e57-62. x-wiley/crsRef/2995784
181. Polosa R, Morjaria J, Caponnetto P, Caruso M, Strano S, Battaglia E, et al. Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal. International Journal of Environmental Research & Public Health 2014;11(5):4965-77. x-wiley/crsRef/2995729
182. Ling PM, Popova L. Novel "Tobacco" product use and association with smoking cessation: a national study. Journal of General Internal Medicine 2012;27(2 Suppl):S254. x-wiley/crsRef/2995786
183. Popova L, Ling PM. Alternative tobacco product use and smoking cessation: a national study. American Journal of Public Health 2013;103(5):923-30. x-wiley/crsRef/2995787
184. Prochaska JJ, Grana RA. E-cigarette use among smokers with serious mental illness. PLOS One 2014;9(11):e113013. x-wiley/crsRef/4359053
185. Russo C, Cibella F, Mondati E, Caponnetto P, Frazzetto E, Caruso M, et al. Lack of substantial post-cessation weight increase in electronic cigarettes users. International Journal of Environmental Research and Public Health 2018;15(4):581. x-wiley/crsRef/14702676
186. Schober W, Szendrei K, Matzen W, Osiander-Fuchs H, Heitmann D, Schettgen T, et al. Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. International Journal of Hygiene and Environmental Health 2014;217(6):628-37. x-wiley/crsRef/2995789
187. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking-cessation tool: results from an online survey. American Journal of Preventive Medicine 2011;40(4):472-5. x-wiley/crsRef/2995791
188. Song M-A, Reisinger SA, Freudenheim JL, Brasky TM, Mathe EA, McElroy JP, et al. Effects of electronic cigarette constituents on the human lung: a pilot clinical trial. Cancer Prevention Research 2020;13(2):145-52. x-wiley/crsRef/14702678
189. StHelen G, Nardone N, Addo N, Dempsey D, Havel C, Jacob P, et al. Differences in nicotine intake and effects from electronic and combustible cigarettes among dual users. Addiction 2020;115(4):757-67. x-wiley/crsRef/14702680
190. Stein JH, Korcarz CE. E-cigarettes versus nicotine-replacement therapy for smoking cessation. New England Journal of Medicine 2019;380(20):1973-4. x-wiley/crsRef/14702682
191. Stower H. E-cigarettes to help smoking cessation. Nature Medicine 2019;25(3):358. x-wiley/crsRef/14702684
192. Tsikrika S, Vakali S, Gennimata SA, Palamidas A, Kaltsakas G, Koulouris N, et al. Short term use of an e-cig: influence on clinical symptoms, vital signs and eCO levels. Tobacco Induced Diseases 2014;12(Suppl 1):A30. x-wiley/crsRef/2995793
193. Tucker MR, Laugesen M, Bullen C, Grace RC. Predicting short-term uptake of electronic cigarettes: effects of nicotine, subjective effects, and simulated demand. Nicotine & Tobacco Research 2018;20(10):1265-71. x-wiley/crsRef/14702686
194. Tzatzarakis MN, Tsitoglou KI, Chorti MS, Poulianiti KP, Jamurtas AZ, Koutedakis Y, et al. Acute and short term impact of active and passive tobacco and electronic cigarette smoking on inflammatory markers. Toxicology Letters 2013;221(Suppl):S86. x-wiley/crsRef/2995795
195. Vakali S, Tsikrika S, Gennimata SA, Kaltsakas G, Palamidas A, Koulouris N, et al. E-cigarette acute effect on symptoms and airway inflammation: comparison of nicotine with a non-nicotine cigarette. Tobacco Induced Diseases 2014;12(Suppl 1):A35. x-wiley/crsRef/2995797
196. Valentine GW, Jatlow PI, Coffman M, Nadim H, Gueorguieva R, Sofuoglu M. The effects of alcohol-containing e-cigarettes on young adult smokers. Drug and Alcohol Dependence 2016;159:272-6. x-wiley/crsRef/14702688
197. Van Heel M, Van Gucht D, Vanbrabant K, Baeyens F. The importance of conditioned stimuli in cigarette and e-cigarette craving reduction by e-cigarettes. International Journal of Environmental Research and Public Health 2017;14(2):193. x-wiley/crsRef/14702690
198. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiology, Biomarkers & Prevention 2010;19(8):1945-53. x-wiley/crsRef/2995799
199. Vansickel AR, Weaver MF, Eissenberg T. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction 2012;107(8):1493-500. x-wiley/crsRef/2995801
200. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine & Tobacco Research 2013;15(1):267-70. x-wiley/crsRef/2995803
201. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: Impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012;141(6):1400-6. x-wiley/crsRef/2995805
202. Vickerman KA, Carpenter KM, Altman T, Nash CM, Zbikowski SM. Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine & Tobacco Research 2013;15(10):1787-91. x-wiley/crsRef/2995807
203. Voos N, Kaiser L, Mahoney MC, Bradizza CM, Kozlowski LT, Benowitz NL, et al. Randomized within-subject trial to evaluate smokers' initial perceptions, subjective effects and nicotine delivery across six vaporized nicotine products. Addiction 2019;114(7):1236-48. x-wiley/crsRef/14702692
204. Voos N, Smith D, Kaiser L, Mahoney MC, Bradizza CM, Kozlowski LT, et al. Effect of e-cigarette flavors on nicotine delivery and puffing topography: results from a randomized clinical trial of daily smokers. Psychopharmacology 2020;237(2):491-502. x-wiley/crsRef/14702694
205. Wagener TL, Meier E, Hale JJ, Oliver ER, Warner ML, Driskill LM, et al. Pilot investigation of changes in readiness and confidence to quit smoking after e-cigarette experimentation and 1 week of use. Nicotine & Tobacco Research 2014;16(1):108-14. x-wiley/crsRef/2995809
206. Walele T, Sharma G, Savioz R, Martin C, Williams J. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part A: Pharmacokinetics. Regulatory Toxicity 2016;74:187-92. x-wiley/crsRef/4359066
207. Walele T, Sharma G, Savioz R, Martin C, Williams J. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B: Safety and subjective effects. Regulatory Toxicity 2016;74:193-9. x-wiley/crsRef/4359068
208. Yan XS, D'Ruiz C. Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regulatory Toxicology and Pharmacology 2015;71(1):24-34. x-wiley/crsRef/4359070
209. Yuki D, Sakaguchi C, Kikuchi A, Futamura Y. Pharmacokinetics of nicotine following the controlled use of a prototype novel tobacco vapor product. Regulatory Toxicology and Pharmacology 2017;87(2):30-5. x-wiley/crsRef/14702696
210. Zhang Y, Upson D. E-cigarettes versus nicotine-replacement therapy for smoking cessation. New England Journal of Medicine 2019;380(20):1973. x-wiley/crsRef/14702698
211. ACTRN12617001324303. Vaporised nicotine products versus oral forms of nicotine replacement therapy (NRT) products for tobacco smoking cessation among low-socioeconomic status (low-SES) smokers. anzctr.org.au/ACTRN12617001324303.aspx (first received 15 September 2017). x-wiley/crsRef/14702700
212. ACTRN12618000408280. Cessation and Relapse Prevention (CARP) Trial: Nicotine vaporisers compared to standard nicotine replacement therapy for smoking cessation among people with co-morbidities. www.anzctr.org.au/ACTRN12618000408280.aspx (first received 21 March 2018). x-wiley/crsRef/14702702
213. ACTRN12619001787178. Project NEAT: nicotinE As Treatment for tobacco smoking following discharge from residential withdrawal services. www.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12619001787178 (first received 18 November 2019). x-wiley/crsRef/17072007
214. Begh R, Coleman T, Yardley L, Barnes R, Naughton F, Gilbert H, et al. Examining the effectiveness of general practitioner and nurse promotion of electronic cigarettes versus standard care for smoking reduction and abstinence in hardcore smokers with smoking-related chronic disease: protocol for a randomised controlled trial. Trials 2019;20(1):659. x-wiley/crsRef/14702704
215. ISRCTN59404712. GP/nurse promotion of e-cigarettes in supporting reduced smoking and cessation in smokers. www.isrctn.com/ISRCTN59404712 (first received 28 November 2017). x-wiley/crsRef/14702705
216. Berlin I, Dautzenberg B, Lehmann B, Palmyre J, Liégey E, De Rycke Y, et al. Randomised, placebo-controlled, double-blind, double-dummy, multicentre trial comparing electronic cigarettes with nicotine to varenicline and to electronic cigarettes without nicotine: the ECSMOKE trial protocol. BMJ Open 2019;9(5):e028832. x-wiley/crsRef/14702707
217. NCT03630614. Randomized trial of electronic cigarettes with or without nicotine in smoking cessation (ECSMOKE). clinicaltrials.gov/ct2/show/NCT03630614 (first received 15 August 2018). x-wiley/crsRef/14702708
218. Caponnetto P, Polosa R, Auditore R, Minutolo G, Signorelli M, Maglia M, et al. Smoking cessation and reduction in schizophrenia (SCARIS) with e-cigarette: study protocol for a randomized control trial. Trials [electronic resource] 2014;15:88. x-wiley/crsRef/2995813
219. NCT01979796. Antismoking effects of rlectronic cigarettes in subjects with schizophrenia and their potential influence on cognitive functioning: design of a randomized trial. Smoking Cessation And Reduction In Schizophrenia (The SCARIS Study). clinicaltrials.gov/show/NCT01979796 (accessed 16 July 2014). x-wiley/crsRef/2995814
220. Caponnetto P, Caruso M, Maglia M, Emma R, Saitta D, Busa B, et al. Non-inferiority trial comparing cigarette consumption, adoption rates, acceptability, tolerability, and tobacco harm reduction potential in smokers switching to Heated Tobacco Products or electronic cigarettes: Study protocol for a randomized controlled trial. Contemporary Clinical Trials Communications 2020;8:17. x-wiley/crsRef/17072009
221. ACTRN12612001210864. An open-label randomised pragmatic policy trial examining effectiveness of short-term use of Nicotine Replacement Therapy (NRT) vs short- or long-term use of NRT vs short- or long-term use of NRT or electronic nicotine delivery systems for smoking cessation in cigarette smokers. ACTRN12612001210864 (accessed 15 August 2016). x-wiley/crsRef/2995811
222. Fraser D, Borland R, Gartner C. Protocol for a randomised pragmatic policy trial of nicotine products for quitting or long-term substitution in smokers. BMC Public Health 2015;15:1026. x-wiley/crsRef/4359071
223. ISRCTN13288677. Can electronic cigarettes and nicotine replacement treatment help reduce smoking in smokers who struggle to quit? www.isrctn.com/ISRCTN13288677 (first received 17 March 2017). x-wiley/crsRef/14702710
224. ISRCTN61193406. Do e-cigarettes help smokers quit when not accompanied by intensive behavioural support? www.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN61193406 2020 (first received 11 August 2020). x-wiley/crsRef/17072011
225. Klonizakis M, Crank H, Gumber A, Brose LS. Smokers making a quit attempt using e-cigarettes with or without nicotine or prescription nicotine replacement therapy: Impact on cardiovascular function (ISME-NRT) - a study protocol. BMC Public Health 2017;17(1):293. x-wiley/crsRef/14702712
226. NCT03061253. E-cigarettes and cardiovascular function (ISME-NRT). clinicaltrials.gov/ct2/show/NCT03061253 (first received 23 February 2017). x-wiley/crsRef/14702713
227. Murray RL, Brain K, Britton J, Quinn-Scoggins HD, Lewis S, McCutchan GM, et al. Yorkshire Enhanced Stop Smoking (YESS) study: a protocol for a randomised controlled trial to evaluate the effect of adding a personalised smoking cessation intervention to a lung cancer screening programme. BMJ Open 2020;10(9):e037086. x-wiley/crsRef/17072013
228. NCT01842828. E-Cigarettes as an addition to multi-component treatment for tobacco dependence: a pilot study. clinicaltrials.gov/show/NCT01842828 (accessed 16 July 2014). x-wiley/crsRef/4359078
229. NCT01989923. Immediate smoking cessation for patients at risk for cervical dysplasia, cervical cancer and lower genital tract dysplasia and cancer - a feasibility study comparing nicotine replacement therapy with the electronic nicotine delivery system. clinicaltrials.gov/show/NCT01989923 (accessed 16 July 2014). x-wiley/crsRef/2995827
230. NCT02004171. Electronic nicotine delivery devices (ENDDs) or nicotine inhaler for smoking cessation. clinicaltrials.gov/show/NCT02004171 (accessed 16 July 2014). x-wiley/crsRef/2995829
231. NCT02124187. Smoking cessation and reduction in depression (SCARID). clinicaltrials.gov/show/NCT02124187 (accessed 16 July 2014). x-wiley/crsRef/2995833
232. NCT02398487. Head-to-head comparison of personal vaporizers versus cigalike: prospective 6-month randomized control design study. clinicaltrials.gov/show/NCT02398487 (accessed 17 February 2016). x-wiley/crsRef/4359088
233. NCT02527980. E-cigarettes: dynamic patterns of use and health effects. clinicaltrials.gov/show/NCT02527980 (accessed 17 February 2016). x-wiley/crsRef/4359100
234. NCT02590393. The role of nicotine and non-nicotine alkaloids in e-cigarette use and dependence. clinicaltrials.gov/show/NCT02590393 (accessed 17 February 2016). x-wiley/crsRef/4359102
235. NCT02635620. Changes in lung function parameters, bronchial reactivity, state of health and smoking behaviour associated with changing from conventional smoking to electronic cigarettes. clinicaltrials.gov/show/NCT02635620 (accessed 17 February 2016). x-wiley/crsRef/4359106
236. NCT03589989. The ESTxENDS Trial- Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cigarette) as an aid for smoking cessation. (ESTxENDS). clinicaltrials.gov/ct2/show/record/NCT03589989 (first received 18 July 2018). x-wiley/crsRef/14702717
237. NCT03603340. The ESTxENDS Trial- Effects of using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig) on depression (ESTxENDS). clinicaltrials.gov/show/NCT03603340 (first received 27 July 2018). x-wiley/crsRef/14702718
238. NCT03603353. The ESTxENDS Trial- Effects of using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig) on sleep quality. (ESTxENDS). clinicaltrials.gov/show/NCT03603353 (first received 27 July 2018). x-wiley/crsRef/14702719
239. NCT03612336. The ESTxENDS Trial- Metabolic effects of using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig) (ESTxENDS). clinicaltrials.gov/show/NCT03612336 (first received 2 August 2018). x-wiley/crsRef/14702720
240. NCT03612375. ESTxENDS Trial-Oxidative stress induced by Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig) measured in urine (ESTxENDS). clinicaltrials.gov/show/NCT03612375 (first received 2 August 2018). x-wiley/crsRef/14702721
241. NCT03612453. ESTxENDS Trial- Oxidative stress induced by Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig) measured in EBC (ESTxENDS). clinicaltrials.gov/show/NCT03612453 (first received 2 August 2018). x-wiley/crsRef/14702722
242. NCT03612544. The ESTxENDS Trial- Toxins from using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig) (ESTxENDS). clinicaltrials.gov/show/NCT03612544 (first received 2 August 2018). x-wiley/crsRef/14702723
243. NCT03632421. The ESTxENDS Trial-effects of using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig) on respiratory symptoms (ESTxENDS). clinicaltrials.gov/show/NCT03632421 (first received 15 August 2018). x-wiley/crsRef/14702724
244. NCT03938298. The ESTxENDS Trial: Pulmonary function substudy (PulmENDS). clinicaltrials.gov/ct2/show/nct03938298 (first received 6 May 2019). x-wiley/crsRef/14702725
245. NCT04236791. The ESTxENDS Trial- Electronic Nicotine Delivery Systems as an aid for smoking cessation-extension of follow-up. clinicaltrials.gov/show/NCT04236791 2020 (first received 22 January 2020). x-wiley/crsRef/17072014
246. NCT04244773. ESTxENDS Trial: MN Substudy - Micronuclei in buccal epithelium, a surrogate measure of future cancer risk, induced by Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig). clinicaltrials.gov/show/NCT04244773 (first receved 28 January 2020). x-wiley/crsRef/17072015
247. NCT04617444. The ESTxENDS Trial- Effects of using Electronic Nicotine Delivery Systems (ENDS/Vaporizer/E-cig) on olfactory function. clinicaltrials.gov/show/NCT04617444 (first received 05 November 2020). x-wiley/crsRef/17072016
248. NCT03700112. Clinical study comparing 7 ENDS products and 1 combustible cigarette using 2 delivery methods. clinicaltrials.gov/ct2/show/NCT03700112 (first received 7 December 2018). x-wiley/crsRef/14702727
249. NCT03962660. Harm Reduction for Tobacco Smoking with support of Tobacco-Rreplacing Electronic Nicotine Delivery Systems (HaRTS-TRENDS). clinicaltrials.gov/ct2/show/record/NCT03962660 (first received 24 May 2019). x-wiley/crsRef/14702729
250. NCT04063267. Electronic cigarettes as a harm reduction strategy in individuals with substance use disorder. clinicaltrials.gov/ct2/show/NCT04063267 (first received 21 August 2019). x-wiley/crsRef/14702731
251. NCT04231838. Metabolic syndrome in diabetic smokers using cigarettes & combustion-free nicotine delivery systems. clinicaltrials.gov/show/NCT04231838 (first received 18 January 2020). x-wiley/crsRef/17072018
252. NCT04238832. Salt-based e-cigarette and IQOS Study. clinicaltrials.gov/show/NCT04238832 (firs treceived 18 January 2020). x-wiley/crsRef/17072020
253. NCT04452175. Cigarette consumption after switchinG to high or low nicotine strENght E-cigaretteS In Smokers With Schizophrenia (GENESIS). clinicaltrials.gov/show/NCT04452175 2020 (first received 30 June 2020). x-wiley/crsRef/17072022
254. NCT04649645. International randomized controlled trial evaluating changes in oral health in smokers after switching to combustion-free nicotine delivery systems. clinicaltrials.gov/show/NCT04649645 (first received 02 December 020). x-wiley/crsRef/17072024
255. Akiyama Y, Sherwood N. Systematic review of biomarker findings from clinical studies of electronic cigarettes and heated tobacco products. Toxicology Reports 2021;8:282-94.
256. Amato L, Cruciani F, Solimini R, Barca A, Pacifici R, Davoli M. Effects of electronic cigarettes on health: a systematic review of the available evidence. Recenti Progressi in Medicina 2020;111(1):30-43.
257. Action on Smoking and Health. Use of electronic cigarettes (vapourisers) among adults in Great Britain. ash.org.uk/information-and-resources/fact-sheets/statistical/use-of-e-cigarettes-among-adults-in-great-britain-2019/ (accessed 21 July 2020).
258. Balfour D. The neurobiology of tobacco dependence: a preclinical perspective on the role of dopamine projections to the nucleus. Nicotine & Tobacco Research 2004;6(6):899-912.
259. Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addiction: Science & Clinical Practice 2013;8(1):5.
260. Barrett SP. The effects of nicotine, denicotinized tobacco, and nicotine-containing tobacco on cigarette craving, withdrawal, and self-administration in male and female smokers. Behavorial Pharmacology 2010;21(2):144-52.
261. Benowitz NL. Nicotine addiction. New England Journal of Medicine 2010;362(24):2295-303.
262. Besaratinia A, Tommasi S. Vaping: a growing global health concern. EClinicalMedicine 2019;17:100208.
263. Blount BC, Karwowski MP, Shields PG, Morel-Espinosa M, Valentin-Blasini L, Gardner M, et al. Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI. New England Journal of Medicine 2020;382(8):697-705.
264. Brooker J, Synnot A, McDonald S, Elliott J, Turner T, et al. Guidance for the production and publication of Cochrane living systematic reviews: Cochrane Reviews in living mode;December 2019. community.cochrane.org/sites/default/files/uploads/inline-files/Transform/201912_LSR_Revised_Guidance.pdf (accessed 30 July 2020).
265. Cahill K, Lindson-Hawley N, Thomas K, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2016, Issue 5. Art. No: CD006103. [DOI: 10.1002/14651858.CD006103.pub7]
266. Centres for Disease Control and Prevention. Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html#latest-outbreak-information Feb 2020 (accessed 12 Aug 2020).
267. Chen C, Zhuang YL, Zhu SH. E-cigarette design preference and smoking cessation: a U.S. population study. American Journal of Preventive Medicine 2016;51(3):356-63. [DOI: 10.1016/j.amepre.2016.02.002]
268. Veritas Health Innovation Covidence. Version accessed 30 July 2020. Melbourne, Australia: Veritas Health Innovation. Available at covidence.org.
269. Cox S, Jakes S. Nicotine and e-cigarettes: rethinking addiction in the context of reduced harm. International Journal of Drug Policy 2017;44:84-5.
270. Cox S, Leigh NJ, Vanderbush TS, Choo E, Goniewicz ML, Dawkins L. An exploration into "do-it-yourself" (DIY) e-liquid mixing: sers' motivations, practices and product laboratory analysis. Addictive Behaviors Reports 2019;9:100151.
271. Dawkins L, Turner J, Roberts A, Soar K. 'Vaping' profiles and preferences: an online survey of electronic cigarette users. Addiction 2013;108(6):1115-25.
272. Dawkins LE, Kimber CF, Doig M, Feyerabend C, Corcoran O. Self-titration by experienced e-cigarette users: blood nicotine delivery and subjective effects. Psychopharmacology (Berl) 2016;233(14-16):2933-41. [DOI: 10.1007/s00213-016-4338-2]
273. Dawkins L, Cox S, Goniewicz M, McRobbie H, Kimber C, Doig M, et al. 'Real-world' compensatory behaviour with low nicotine concentration e-liquid: subjective effects and nicotine, acrolein and formaldehyde exposure. Addiction 2018;113(10):1874-82.
274. Donny EC, Houtsmuller E, Stitzer ML. Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction 2007;102(2):324-34.
275. Donny EC, Jones M. Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine. Drug and Alcohol Dependence 2009;104(1-2):23-33.
276. Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, et al. Randomized trial of reduced-nicotine standards for cigarettes. New England Journal of Medicine 2015;373(14):1340-9.
277. Du Y, Liu B, Xu G, Rong S, Sun Y, Wu Y, et al. Association of electronic cigarette regulations with electronic cigarette use among adults in the United States. JAMA Network Open 2020;3(1):e1920255.
278. E-cigarette v1. Qeios. [URL: www.qeios.com/read/0WX80U]
279. Etter JF, Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 2011;106(11):2017-28.
280. European Parliament and Council of the European Union. Directive 2014/40/EU of the European Parliament and of the Council of 3 April 2014 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products and repealing Directive 2001/37/EC. 2014 (accessed 25th November 2014).
281. Fagerström KO, Hughes JR. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review. Nicotine & Tobacco Research 2004;4(Suppl 2):S73-9.
282. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Therapeutic Advances in Drug Safety 2014;5(2):67-86.
283. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine & Tobacco Research 2012;15(1):158-66.
284. Goniewicz ML, Hajek P, McRobbie H. Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction 2014;109(3):500-7.
285. McMaster University (developed by Evidence Prime) GRADEpro GDT. Version accessed 30 July 2020. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.
286. Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Archives of Internal Medicine 1999;159(17):2033-8.
287. Hajek P, Etter J-F, Benowitz N, Eissenberg T, McRobbie H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction 2014;109(11):1801-10.
288. Hajek P, Goniewicz ML, Phillips A, Myers Smith K, West O, McRobbie H. Nicotine intake from electronic cigarettes on initial use and after 4 weeks of regular use. Nicotine & Tobacco Research 2015;17(2):175-9.
289. Hajek P, Przulj D, Phillips A, Anderson R, McRobbie H. Nicotine delivery to users from cigarettes and from different types of e-cigarettes. Psychopharmacology (Berl) 2017;234(5):773-9.
290. Hajek P, Pittaccio K, Pesola F, Myers Smith K, Phillips-Waller A, Przulj D. Nicotine delivery and users' reactions to Juul compared with cigarettes and other e-cigarette products. Addiction 2020;115(6):1141-8.
291. Hall W, Gartner C, Bonevski B. Lessons from the public health responses to the US outbreak of vaping-related lung injury. Addiction 2020 [Epub ahead of print].
292. Hammond D, Rynard VL, Reid JL. Changes in prevalence of vaping among youths in the United States, Canada, and England from 2017 to 2019. JAMA Pediatrics 2020;174(8):797-800.
293. Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews 2018, Issue 5. Art. No: CD000146. [DOI: 10.1002/14651858.CD000146.pub5]
294. Hartmann-Boyce J, Fanshawe TR, Lindson N, Livingstone-Banks J, Ordonez-Mena J, Aveyard P. Behavioural interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database of Systematic Reviews 2018, Issue 12. Art. No: CD013229. [DOI: 10.1002/14651858.CD013229]
295. Hartmann-Boyce J, Hong B, Livingstone-Banks J, Wheat H, Fanshawe TR. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation. Cochrane Database of Systematic Reviews 2019, Issue 6. Art. No: CD009670. [DOI: 10.1002/14651858.CD009670.pub4]
296. Hartnett KP, Kite-Powell A, Patel MT, Haag BL, Sheppard MJ, Dias TP, et al. Syndromic surveillance for e-cigarette, or vaping, product use-associated lung injury. New England Journal of Medicine 2020;382(8):766-72.
297. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
298. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
299. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). The Cochrane Collaboration, 2021. Available from www.training.cochrane.org/handbook.
300. Hitchman SC, Brose LS, Brown J, Robson D, McNeill A. Associations between e-cigarette type, frequency of use, and quitting smoking: findings from a longitudinal online panel survey in Great Britain. Nicotine & Tobacco Research 2015;17(10):1187-94.
301. Huang J, Duan Z, Kwok J, Binns S, Vera LE, Kim Y, et al. Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market. Tobacco Control 2019;28(2):146-51.
302. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004;99(1):29-38.
303. Jiang N, Chen J, Wang MP, McGhee SM, Kwong AC, Lai VW, et al. Electronic cigarette awareness and use among adults in Hong Kong. Addictive Behaviors 2016;52:34-8.
304. Levin ED, Behm F, Carnahan E, LeClair R, Shipley R, Rose JE. Clinical trials using ascorbic acid aerosol to aid smoking cessation. Drug and Alcohol Dependence 1993;33(3):211-23.
305. Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2019, Issue 4. Art. No: CD013308. [DOI: 10.1002/14651858.CD013308]
306. Martinez-Morata I, Sanchez TR, Shimbo D, Navas-Acien A. Electronic cigarette use and blood pressure endpoints: a systematic review. Current Hypertension Reports 2021;23(1):1.
307. McDonald CF, Jones S, Beckert L, Bonevski B, Buchanan T, Bozier J, et al. Electronic cigarettes: a position statement from the Thoracic Society of Australia and New Zealand. Respirology 2020 [Epub ahead of print].
308. McNeill A, Brose LS, Calder R, Bauld L, Robson D. Vaping in England: an evidence update including vaping for smoking cessation, February 2021: a report commissioned by Public Health England London, UK: Public Health England. assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/962221/Vaping_in_England_evidence_update_February_2021.pdf 2021.
309. McRobbie H, Przulj D, Smith KM, Cornwall D. Complementing the standard multicomponent treatment for smokers with denicotinized cigarettes: a randomized trial. Nicotine & Tobacco Research 2016;18(5):1134-41.
310. National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice. Public Health Consequences of E-Cigarettes. Washington (DC): National Academies Press (US), 2018.
311. Notley C, Colllins R. Redefining smoking relapse as recovered social identity - secondary qualitative analysis of relapse narratives. Journal of Substance Use 2018;23(6):660-6.
312. Notley C, Ward E, Dawkins L, Holland R. The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention. Harm Reduct J 2018;15(1):31.
313. Palipudi KM, Mbulo L, Morton J, Bunnell R, Blutcher-Nelson G, Kosen S, et al. Awareness and current use of electronic cigarettes in Indonesia, Malaysia, Qatar, and Greece: findings from 2011–2013 global adult tobacco surveys. Nicotine & Tobacco Research 2016;18(4):501-7.
314. Patnode CD, Henderson JT, Coppola EL, Melnikow J, Durbin S, Thomas RG. Interventions for tobacco cessation in adults, including pregnant persons: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2021;325(3):280-98.
315. Perkins KA, Karelitz JL, Conklin CA, Sayette MA, Giedgowd GE. Acute negative affect relief from smoking depends on the affect situation and measure but not on nicotine. Biological Psychology 2010;67(8):707-14.
316. Pickworth WB, Fant RV, Nelson RA, Rohrer MS, Henningfield JE. Pharmacodynamic effects of new de-nicotinized cigarettes. Nicotine & Tobacco Research 1999;1(4):357-64.
317. Przulj D, McRobbie H, Hajek P. The effect of sensorimotor replacement on smoking cessation and craving. Open Addiction Journal 2013;5:41-50.
318. Tobacco Advisory Group of the Royal College of Physicians. Nicotine Without Smoke—Tobacco Harm Reduction. London: Royal College of Physicians, 2016.
319. Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5). Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020.
320. Romeu ER. Voke® nicotine inhaler for smoking cessation and reduction. ntag.nhs.uk/docs/app/NTAG-Apprasial-Voke-nicotine-inhalator-Feb-2020-final-for-web.pdf 2020.
321. Rose JE, Tashkin DP, Ertle A, Zinser MC, Lafer R. Sensory blockade of smoking satisfaction. Pharmacology Biochemistry & Behavior 1985;23(2):289-93.
322. Rose JE, Behm FM, Levin ED. Role of nicotine dose and sensory cues in the regulation of smoke intake. Pharmacology Biochemistry & Behavior 1993;44(4):891-900.
323. Rose JE, Behm FM. Inhalation of vapor from black pepper extract reduces smoking withdrawal symptoms. Drug and Alcohol Dependence 1994;34(3):225-9.
324. Rose JE, Behm FM, Westman EC, Johnson M. Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacology Biochemistry & Behavior 2000;67(1):71-81.
325. Rose JE. Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology 2006;184(3-4):274-85.
326. Russell MA. Nicotine intake and its control over smoking. In: Wonnacott S, Russell MA, Stolerman I, editors(s). Nicotine Psychopharmacology: Molecular, Cellular and Behavioural Aspects. London: Oxford University Press, 1990:374-418.
327. Schneider NG, Olmstead RE, Franzon MA, Lunell E. The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments. Clinical Pharmcokinetics 2001;40(9):661-84.
328. Smets J, Baeyens F, Chaumont M, Adriaens K, Van Gucht D. When less is more: vaping low-nicotine vs. high-nicotine e-liquid is compensated by increased wattage and higher liquid consumption. International Journal of Environmental Research and Public Health 2019;16(5):723.
329. Talih S, Salman R, El-Hage R, Karam E, Salam S, Karaoghlanian N, et al. A comparison of the electrical characteristics, liquid composition, and toxicant emissions of JUUL USA and JUUL UK e-cigarettes. Scientific Reports 2020;10(1):7322.
330. Tattan-Birch H, Brown J, Shahab L, Jackson SE. Association of the US outbreak of vaping-associated lung injury with perceived harm of e-cigarettes compared with cigarettes. JAMA Network Open 2020;3(6):e206981.
331. Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons. U.S. Preventive Services Task Force 2021:www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions.
332. Walker N, Howe C, Bullen C, Grigg M, Glover M, McRobbie H, et al. The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial. Addiction 2012;107(10):1857-67.
333. Wang RJ, Bhadriraju S, Glantz SA. E-Cigarette Use and Adult Cigarette Smoking Cessation: A Meta-Analysis. American Journal of Public Health 2021;111:230-46.
334. Westman EC, Behm FM, Rose JE. Airway sensory replacement combined with nicotine replacement for smoking cessation. A randomized, placebo-controlled trial using a citric acid inhaler. Chest 1995;107(5):1358-64.
335. Westman EC, Behm FM, Rose JE. Dissociating the nicotine and airway sensory effects of smoking. Pharmacology Biochemistry & Behavior 1996;53(2):309-15.
336. Yingst JM, Foulds J, Veldheer S, Hrabovsky S, Trushin N, Eissenberg TT, et al. Nicotine absorption during electronic cigarette use among regular users. PLOS One 2019;14(7):e0220300.
337. Yingst JM, Hrabovsky S, Hobkirk A, Trushin N, Richie JP Jr, Foulds J. Nicotine absorption profile among regular users of a pod-based electronic nicotine delivery system. JAMA Network Open 2019;2(11):e1915494.
338. Zhang YY, Bu FL, Dong F, Wang JH, Zhu SJ, Zhang XW, et al. The effect of e-cigarettes on smoking cessation and cigarette smoking initiation: an evidence-based rapid review and meta-analysis. Tobacco Induced Diseases 2021;19(4). [DOI: 10.18332/tid/131624]
339. Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews 2016, Issue 9. Art. No: CD010216. [DOI: 10.1002/14651858.CD010216.pub3]
340. Hartmann-Boyce J, McRobbie H, Lindson N, Bullen C, Begh R, Theodoulou A, et al. Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews 2020, Issue 10. Art. No: CD010216. [DOI: 10.1002/14651858.CD010216.pub4]
341. McRobbie H, Bullen C, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No: CD010216. [DOI: 10.1002/14651858.CD010216]
342. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database of Systematic Reviews 2014, Issue 12. Art. No: CD010216. [DOI: 10.1002/14651858.CD010216.pub2]